Microbicides: Information, beliefs, and preferences for insertion

Journal of Women's Health

Volumn 16, Issue 10, 2007, Pages 1458-1467

  Auslander, Beth A ^a   Perfect, Michelle M ^a   Breitkopf, Daniel M ^b   Succop, Paul A ^c   Rosenthal, Susan L ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROBICIDE;

ADULT; ARTICLE; BATH; BIRTH CONTROL; DEMOGRAPHY; FEMALE; HEALTH BEHAVIOR; HUMAN; INTERVIEW; MENSTRUATION; PHARMACIST; PHYSICIAN; PRIORITY JOURNAL; SEXUAL INTERCOURSE; SEXUALITY; STRUCTURED QUESTIONNAIRE; UNITED STATES; UNIVARIATE ANALYSIS;

ADMINISTRATION, INTRAVAGINAL; ADULT; ANTI-INFECTIVE AGENTS, LOCAL; ANTI-RETROVIRAL AGENTS; CHOICE BEHAVIOR; CONTRACEPTION BEHAVIOR; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; PATIENT SATISFACTION; QUESTIONNAIRES; SEXUALLY TRANSMITTED DISEASES, VIRAL; SPERMATOCIDAL AGENTS; TEXAS; WOMEN'S HEALTH;

EID: 36848998825     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2006.0190     Document Type: Article

References (33)

1. Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004;36:6.
2. Centers for Disease Control and Prevention. Trends in reportable sexually transmitted diseases in the United States, 2004: National surveillance data for chlamydia, gonorrhea, and syphilis, 2005.
3. Centers for Disease Control and Prevention. HIV/AIDS surveillance report, 2004. Vol 16. In: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2005.
4. Winer RL, Hughes JP, Feng Q, et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006;354:2645.
5. Casper C, Wald A. Condom use and the prevention of genital herpes acquisition. Herpes 2002;9:10.
6. Weller S, Davis KR. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev 2001;3:3255.
7. Pulerwitz J, Amaro H, De Jong W, Gortmaker SL, Rudd R. Relationship power, condom use, and HIV risk among women in the U.S.A. AIDS Care 2002;14:789.
8. Rosenthal SL, Cohen SS, Stanberry LR. Topical microbicides: Current status and research considerations for adolescent girls. Sex Transm Dis 1998;25:368.
9. Alliance for Microbicide Development. Products in clinical development. In: Microbicide watch. Silver Spring, MD: Alliance for Microbicide Development; 2006:7.
10. Stein Z, Myer L, Susser M. The design of prophylactic trials for HIV: The case of microbicides. Epidemiology 2003;14:80.
11. Harvey SM, Beckman LJ, Murray J. Factors associated with use of the contraceptive sponge. Fam Plann Perspect 1989;21:179.
12. Lamvu G, Steiner MJ, Condon S, Hartmann K. Consistency between most important reasons for using contraception and current method used: The influence of health care providers. Contraception 2006;73:399.
13. Chalmers B, Sand M, Muggah H, et al. Contraceptive knowledge, attitudes and use among women attending health clinics in St. Petersburg, Russian Federation. Can J Hum Sex 1998;7:129.
14. van Lunsen RH, Arnolds HT, van Maris MG. Choices and changes in contraceptive behaviour: The role of information sources. Patient Educ Couns 1994;23:197.
15. Masatu MC, Kvale G, Klepp KI. Frequency and perceived credibility of reported sources of reproductive health information among primary school adolescents in Arusha, Tanzania. Scand J Public Health 2003;31:216.
16. Hammett TM, Mason TH, Joanis CL, et al. Acceptability of formulations and application methods for vaginal microbicides among drug involved women: Results of product trials in three cities. Sex Transm Dis 2000;27:119.
17. Short MB, Mills L, Majkowski JM, Stanberry LR, Rosenthal SL. Topical microbicide use by adolescent girls: Concerns about timing, efficacy, and safety. Sex Transm Dis 2003;30:854.
18. Hammett TM, Norton GD, Mason TH, et al. Drug-involved women as potential users of vaginal microbicides for HIV and STD prevention: A three-city survey. J Womens Health Gend Based Med 2000;9:1071.
19. Short MB, Mills L, Majkowski JM, Stanberry LR, Rosenthal SL. Adolescent issues associated with knowledge of and access to topical microbicides. J Womens Health 2004;13:1127.
20. Murphy P, Kirkman A, Hale RW. A national survey of women's attitudes toward oral contraception and other forms of birth control. Womens Health Issues 1995;5:94.
21. Tessler SL, Peipert JF. Perception of contraceptive effectiveness and health effects of oral contraception. Womens Health Issues 1997;7:400.
22. Romo LF, Berenson AB, Wu ZH. The role of misconceptions on Latino women's acceptance of emergency contraceptive pills. Contraception 2004;69:227.
23. Misconceptions about condom efficacy linked to high risk of unprotected sex among Chinese STD patients. Int J Fam Plann Perspect 2003;29:192.
24. Bentley ME, Fullem AM, Tolley EE, et al. Acceptability of a microbicide among women and their partners in a 4-country phase I trial. Am J Public Health 2004;94:1159.
25. Weeks MR, Mosack KE, Abbott M, et al. Microbicide acceptability among high-risk urban U.S. women: Experiences and perceptions of sexually transmitted HIV prevention. Sex Transm Dis 2004;31:682
26. Mauck C, Frezieres R, Walsh T, Robergeau K, Callahan M. Cellulose sulfate: Tolerance and acceptability of penile application. Contraception 2001;64:377.
27. Tabet SR, Callahan MM, Mauck CK, et al. Safety and acceptability of penile application of 2 candidate topical microbicides: BufferGel and PRO 2000 Gel. J Acquire Immun Defic Syndr 2003;33:476.
28. Schwartz JL. Male tolerance of ACIDFORM gel. Contraception 2005;71:443.
29. Ramjee G, Gouws E, Andrews A, Myer L, Weber AE. The acceptability of a vaginal microbicide among South African men. Int J Fam Plann Perspect 2001;27:164.
30. Darroch JE, Frost JJ. Women's interest in vaginal microbicides. Fam Plann Perspect 1999;31:16.
31. Mosack KE, Weeks MR, Novick SL, Abbott M. Highrisk women's willingness to try a simulated vaginal microbicide: Results from a pilot study. Womens Health 2005;42:71.
32. Short MB, Succop PA, Ugueto AM, Rosenthal SL. Predictors of using a microbicide-like product among adolescent girls. J Adolesc Health 2007;41:357.
33. Elias C, Coggins C. Acceptability research on female-controlled barrier methods to prevent heterosexual transmission of HIV: Where have we been? Where are we going? J Womens Health Gend Based Med 2001;20:163.